Wait-and-See Policy as a First-Line Management for Extra-Abdominal Desmoid Tumors
- 16 April 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Bone and Joint Surgery
- Vol. 96 (8), 631-638
- https://doi.org/10.2106/jbjs.m.00988
Abstract
Background: Extra-abdominal desmoid tumors are rare, locally aggressive neoplasms without metastatic potential. There is no clear consensus regarding their optimal management. The disappointing results of current treatments and the ability of extra-abdominal desmoid tumors to spontaneously stabilize have increasingly drawn interest toward conservative management. The objective of this study was to evaluate a wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. Methods: This two-center retrospective study involved fifty-five patients with a histologically proven extra-abdominal desmoid tumor. The primary outcome was the cumulative probability of dropping out from the wait-and-see policy. The wait-and-see policy included aggressive management of symptoms. We conducted a review of the relevant published series in which a watchful-waiting strategy was used. Results: The cumulative probability of dropping out from the wait-and-see policy was 9.6% at the time of the last follow-up. Spontaneous arrest of tumor growth was noted for forty-seven patients (85%) over the course of the study. Half of the tumors were stabilized at one year, and a potential to increase beyond three years was a sporadic event (one case). Regrowth was found in two patients (4%). Conclusions: A wait-and-see policy is an effective front-line management for patients with primary or recurrent extra-abdominal desmoid tumor. These tumors tend to stabilize spontaneously, on average after one year of evolution, and the cumulative probability of the failure of a wait-and-see policy is approximately 10%. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.Keywords
This publication has 41 references indexed in Scilit:
- The treatment of desmoid tumors: a stepwise clinical approachAnnals Of Oncology, 2012
- Extra-Abdominal Desmoid Tumours: A Review of the LiteratureSarcoma, 2012
- Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumorsGenes, Chromosomes and Cancer, 2010
- A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 casesEuropean Journal of Surgical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patientsEuropean Journal of Surgical Oncology, 2008
- Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouseBMC Genomics, 2007
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Desmoid tumour: a pleomorphic lesionEuropean Journal of Surgical Oncology, 1999
- Aggressive Fibromatosis: Evidence for a Stable PhaseSarcoma, 1998